Skip to content

Marlies Devos, Huisarts

Active
Private limited companyfounded 2021active for 4 yearsBosstraat 132, 9255 Buggenhout, BelgiumKBO/BCE: BE 0777.871.506
Summary

Marlies Devos, Huisarts has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €75,708 and a net result of €72,976. Equity is growing by about 38% per year across the filed financial years. Its solvency ranks better than 35% of 20,598 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€169,682total assets 2025
Equity
€75,708
Profit
€72,976
Turnover not published (micro format)
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts on time1 deed in the Belgian Official Gazette
Why 93lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.62, cash €96,511Size: total assets €169,682Figures for financial year 2025 (filed 31-07-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 45% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 70-30
equity 44.6% of total assets
Liquidity 72+19
short-term debt 55.4% · cash 56.9%
Profitability 100=
return on assets 43.0%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,117 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025highest value 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €7,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.62, compared with 3.3 in 2024, above the usual 1.5; short-term debt: 55.4% and cash: 56.9% of total assets), but 55.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 36% on solvency, 53% on liquidity, 80% on profitability and 13% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.62, cash €96,511
NBB · annual accounts
lowers risk · Size: total assets €169,682
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 31-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
on the day
2024
42 days early
2023
30 days early
2022
28 days early
2021
1 day early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 20 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Annual accounts filedfinancial year 2023 · micro…

Key points

  • Caution: Equity fell in 2025from €142,732 to €75,708 ▼ 47.0% View
  • Positive: Always filed on timeaccounts within the deadline every year 5 years View
  • Positive: 5 profitable years in a rowprofit 2025: €72,976 5 years View

By topic

Financials

Financial year
2025
Total assets
€169,682
Profit
€72,976
Solvency
44.6%
Total assets▼ 10.8%
Net result
20212025
Go to Financials

Timeline

Events
7
Since
2022
Next accounts
by 31-07-2027
  1. 31-12-2023Highest result from 2021 to 2025
  2. 31-12-2023Equity above €150,000
  3. 03-07-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
30-11-2021
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Marlies Devos, Huisarts

What is the company number of Marlies Devos, Huisarts?
0777.871.506. In Belgium the VAT number is the company number with BE in front: BE 0777.871.506.
Where is Marlies Devos, Huisarts based?
The registered office is at Bosstraat 132, 9255 Buggenhout.Company details
What does Marlies Devos, Huisarts do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Marlies Devos, Huisarts?
Private limited company (BV).
When was Marlies Devos, Huisarts founded?
On 30-11-2021.
Is Marlies Devos, Huisarts still active?
Yes, Marlies Devos, Huisarts is an active enterprise in the KBO register.
What is the turnover of Marlies Devos, Huisarts?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Marlies Devos, Huisarts profitable?
In financial year 2025, Marlies Devos, Huisarts made a profit of €72,976.
Where can I find the annual accounts of Marlies Devos, Huisarts?
Marlies Devos, Huisarts filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Marlies Devos, Huisarts due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Marlies Devos, Huisarts

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.